Industry calls for flexibility in FDA’s pediatric measurement guidance
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticals